CVRX Insider Trading
Insider Ownership Percentage: 18.90%
Insider Buying (Last 12 Months): $322,545.00
Insider Selling (Last 12 Months): $19,419.40
CVRx Share Price & Price History
Current Price: $11.75
Price Change: ▲ Price Increase of +0.31 (2.71%)
As of 03/17/2025 05:00 PM ET
CVRx Insider Trading History
CVRx Institutional Trading History
Data available starting January 2016
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Read More on CVRx
Today's Range
Now: $11.75
52 Week Range
Now: $11.75
Volume
91,729 shs
Average Volume
283,330 shs
Market Capitalization
$305.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.34
Who are the company insiders with the largest holdings of CVRx?
Who are the major institutional investors of CVRx?
CVRx's top institutional shareholders include:
- NEA Management Company LLC — 8.35%
- Parkman Healthcare Partners LLC — 3.80%
- JPMorgan Chase & Co. — 2.59%
- Emerald Advisers LLC — 2.45%
- Millennium Management LLC — 1.67%
- Silvercrest Asset Management Group LLC — 1.53%
Learn More about top institutional investors of CVRx stock.
Which institutional investors are selling CVRx stock?
Within the last quarter, CVRX stock was sold by these institutional investors:
- NEA Management Company LLC
- Schonfeld Strategic Advisors LLC
- Balyasny Asset Management L.P.
- Marshall Wace LLP
- Cubist Systematic Strategies LLC
- Nuveen Asset Management LLC
- Archon Capital Management LLC
- Millennium Management LLC
Which institutional investors are buying CVRx stock?
Within the previous quarter, CVRX stock was purchased by institutional investors including:
- JPMorgan Chase & Co.
- Silvercrest Asset Management Group LLC
- Parkman Healthcare Partners LLC
- Emerald Advisers LLC
- Norges Bank
- Emerald Mutual Fund Advisers Trust
- Trexquant Investment LP
- Tradewinds LLC.
In the last year, these company insiders have bought CVRx stock:
- & Johnson Johnson (Major Shareholder)
- Joseph P Slattery (Director)
Learn More investors buying CVRx stock.